Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

GSK 1,467.00 -25.50 (-1.71%)
price chart
Glaxo CEO Says Europe Market 'Much' Worse Than Expected
GlaxoSmithKline Plc (GSK) is having a tougher time than expected generating sales in Europe as the credit crisis leads governments to cut prices, Chief Executive Officer Andrew Witty said.
Related articles »  
Glaxo Gene-Blocking Melanoma Drugs Beat Chemotherapy in Studies
June 4 (Bloomberg) -- Two experimental GlaxoSmithKline Plc drugs that block genes tied to lethal skin cancer worked better than chemotherapy in studies that tested them individually, paving the way for final-phase trials on their use together.
A Drug for Advanced Melanoma Is Found to Prolong Patients' Lives  New York Times
Related articles »  
GSK Receives FDA Approval for MenHibrix�
PHILADELPHIA, June 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix� [Meningococcal Groups C and Y and Haemophilus b Tetanus ...
US approves Glaxo meningitis vaccine for children  Fox News
Related articles »  
Glaxo to Pay at Least $226 Million for Basilea's Toctino
June 12 (Bloomberg) -- GlaxoSmithKline Plc agreed to buy the marketing rights for Basilea Pharmaceutica AG's hand eczema drug Toctino for 146 million pounds ($226 million).
Related articles »  
US top court rules for Glaxo on overtime pay
By a 5-4 vote, the high court handed a defeat to two former sales representatives for a unit of Britain's GlaxoSmithKline Plc. They had appealed a U.S. appeals court in California ruling that they were "outside sales" personnel exempt from federal ...
Related articles »  
KineMed Announces Biomarker Discovery Collaboration with GSK
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) that will apply KineMed's proprietary biomarker discovery platform in ...
Related articles »  
Glaxo, Novartis to get US contracts to make vaccines
WASHINGTON (Reuters) - Pharmaceutical companies including GlaxoSmithKline PLC and Novartis AG will get federal money to help develop medicines against pandemics and bioterrorist threats, the U.S.
Related articles »  
FDA approves XenoPort, GSK's Horizant ER tablets for management of PHN
GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant� (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic ...
Related articles »  
Gene Therapy Gains vs. Cancer
CHICAGO�New data from studies of two GlaxoSmithKline PLC drugs add to the growing body of evidence that targeting tumors based on genetic abnormalities that drive their growth can improve prospects for patients.
Related articles »  
Balanced investment portfolios the easy way
Instead he decided to increase the equity weighting within the fund, investing in a combination of very large companies such as GlaxoSmithKline (GSK) and Unilever (ULVR) with prospects for good dividend growth and strong balance sheets, and quality ...